Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about Aduhelm

Recent news which mentions Aduhelm

Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Biotech BIIB FDA
From Benzinga
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Benzinga General News
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags Benzinga Alzheimer's disease Government
From Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
Tickers BIIB
Tags General Price Target Top Stories
From Benzinga
After Aduhelm Win, Biogen Touts Encouraging Data From Second Alzheimer's Candidate
Tickers BIIB IONS
Tags Briefs Health Care Biotech
From Benzinga
Analysis Shows Biogen-Eisai's Aduhelm Slows Cognitive, Functional Decline In Early Alzheimer's Patients
Tickers BIIB ESALF ESALY
Tags ESALF Benzinga ESALY
From Benzinga
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
Tickers BIIB
Tags Benzinga Short Ideas Briefs
From Benzinga
FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval
Tickers BIIB
Tags Benzinga General Market News
From Benzinga
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
Tickers BIIB ESALY
Tags ESALY Benzinga Aduhelm
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.